Analytical Data
-
Gene name
ZRANB2
- Application
-
Alternative Names
Zinc finger protein 265Zinc finger, splicing
-
Species
Human
-
Source
E. coli
-
Tag
N- His-SUMO
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
O95218
-
Expression Region
1-320aa
-
Molecular Weight
52.3 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
ZRANB2 (Zinc Finger RAN-Binding Domain Containing 2) is a protein of significant interest in the field of molecular biology due to its role in various cellular processes, including RNA metabolism and cell cycle regulation. Research has indicated that ZRANB2 interacts with several key molecular partners, suggesting its involvement in the regulation of gene expression and potential implications in tumorigenesis. Overexpression or mutation of ZRANB2 has been linked to various cancers, highlighting its importance as a potential biomarker and therapeutic target. Additionally, ZRANB2's zinc finger domain suggests a role in protein–protein interactions, making it a critical component in understanding cellular signaling pathways. As a result, the production of recombinant ZRANB2 protein has become essential for in-depth functional studies, enabling researchers to elucidate its mechanistic roles and contributions to disease. The ongoing characterization of ZRANB2 through recombinant protein technology will potentially shed light on its specific functions and pathways, paving the way for novel therapeutic strategies in cancer treatment and other diseases associated with dysregulated RNA metabolism.
